Search Results - "Res, Eleni"

Real-world safety and efficacy data of immunotherapy in patients with cancer and autoimmune disease: the experience of the Hellenic Cooperative Oncology Group by Fountzilas, Elena, Lampaki, Sofia, Koliou, Georgia-Angeliki, Koumarianou, Anna, Levva, Sofia, Vagionas, Anastasios, Christopoulou, Athina, Laloysis, Athanasios, Psyrri, Amanda, Binas, Ioannis, Mountzios, Giannis, Kentepozidis, Nikolaos, Kotsakis, Athanassios, Saloustros, Emmanouil, Boutis, Anastasios, Nikolaidi, Adamantia, Fountzilas, George, Georgoulias, Vassilis, Chrysanthidis, Miltiadis, Kotteas, Elias, Vo, Henry, Tsiatas, Marinos, Res, Eleni, Linardou, Helena, Daoussis, Dimitrios, Bompolaki, Iliada, Andreadou, Anna, Papaxoinis, George, Spyratos, Dionisios, Gogas, Helen, Syrigos, Konstantinos N., Bafaloukos, Dimitrios

“…Background Data on the safety and efficacy of immune checkpoint inhibitors (ICI) in patients with concurrent autoimmune diseases (AID) are limited. Methods We…”
Get full text

Phase 2 study of cabazitaxel as second-line treatment in patients with HER2-negative metastatic breast cancer previously treated with taxanes—a Hellenic Cooperative Oncology Group (HeCOG) Trial by Koutras, Angelos, Zagouri, Flora, Koliou, Georgia-Angeliki, Psoma, Elizabeth, Chryssogonidis, Ioannis, Lazaridis, Georgios, Tryfonopoulos, Dimitrios, Kotsakis, Athanasios, Res, Eleni, Kentepozidis, Nikolaos K., Razis, Evangelia, Psyrri, Amanda, Koumakis, Georgios, Kalofonos, Haralabos P., Dimopoulos, Meletios A., Fountzilas, George

“…Background Cabazitaxel is a novel taxane that might be active in breast cancer resistant to first-generation taxanes. Methods The purpose of the current…”
Get full text

Ten-year clinical outcome, toxicity and compliance of dose-dense sequential adjuvant administration of cyclophosphamide & epirubicin followed by docetaxel in patients with early breast cancer: A hellenic cooperative oncology group observational study (HE 10/10) with concurrent investigation of significance of tumor infiltrating lymphocytes by Dimitrakopoulos, Foteinos-Ioannis, Goussia, Anna, Koliou, Georgia-Angeliki, Dadouli, Katerina, Batistatou, Anna, Kourea, Helen P., Bobos, Mattheos, Arapantoni-Dadioti, Petroula, Tzaida, Olympia, Koletsa, Triantafyllia, Chrisafi, Sofia, Sotiropoulou, Maria, Papoudou-Bai, Alexandra, Nicolaou, Irene, Charchanti, Antonia, Mauri, Davide, Aravantinos, Gerasimos, Binas, Ioannis, Res, Eleni, Psyrri, Amanda, Pectasides, Dimitrios, Bafaloukos, Dimitrios, Koumarianou, Anna, Bompolaki, Iliada, Rigakos, Georgios, Karanikiotis, Charisios, Koutras, Angelos, Zagouri, Flora, Gogas, Helen, Fountzilas, George

“…Dose-dense sequential (dds) chemotherapy has changed the clinical outcome of patients with early breast cancer (BC). To investigate the impact of dose…”
Get full text

RETRO-TAS, a Retrospective Observational Study of Trifluridine/Tipiracil in Chemorefractory Metastatic Colorectal Cancer by Koumarianou, Anna, Ntavatzikos, Anastasios, Symeonidis, David, Vallilas, Christos, Giannakakou, Maria, Papaxoinis, Georgios, Xynogalos, Spyridon, Boukovinas, Ioannis, Demiri, Stamatina, Kampoli, Katerina, Oikonomopoulos, Georgios, Samantas, Epaminontas, Res, Eleni, Androulakis, Nikolaos, Vourli, Georgia, Souglakos, Ioannis, Karamouzis, Michalis

“…Trifluridine/tipiracil (FTD/TPI) is an oral antimetabolite agent comprised of trifluridine, a thymidine-based nucleoside analogue that inhibits cell…”
Get full text

Dose-dense sequential adjuvant chemotherapy in the trastuzumab era: final long-term results of the Hellenic Cooperative Oncology Group Phase III HE10/05 Trial by Zagouri, Flora, Koliou, Georgia-Angeliki, Dimitrakopoulos, Foteinos, Papadimitriou, Christos, Binas, Ioannis, Koutras, Angelos, Papakostas, Pavlos, Markopoulos, Christos, Venizelos, Vasileios, Xepapadakis, Grigorios, Andrikopoulou, Αngeliki, Karanikiotis, Charisios, Psyrri, Amanda, Bafaloukos, Dimitrios, Kosmidis, Paris, Aravantinos, Gerasimos, Res, Eleni, Mauri, Davide, Koumarianou, Anna, Petraki, Kalliopi, Tsipoura, Anna, Pectasides, Dimitrios, Gogas, Helen, Fountzilas, George

“…Background Dose-dense sequential chemotherapy with anthracyclines and taxanes achieved an 18% reduction of recurrence risk in early breast cancer (BC). The…”
Get full text

Responses to SARS-CoV-2 Vaccination in Patients with Cancer (ReCOVer Study): A Prospective Cohort Study of the Hellenic Cooperative Oncology Group by Linardou, Helena, Spanakis, Nikolaos, Koliou, Georgia-Angeliki, Christopoulou, Athina, Karageorgopoulou, Sofia, Alevra, Nephely, Vagionas, Anastasios, Tsoukalas, Nikolaos, Sgourou, Stavroula, Fountzilas, Elena, Sgouros, Joseph, Razis, Evangelia, Chatzokou, Dimitra, Lampaki, Sofia, Res, Eleni, Saridaki, Zacharenia, Mountzios, Giannis, Saroglou, George, Fountzilas, George

“…Data on the effectiveness and safety of approved SARS-CoV-2 vaccines in cancer patients are limited. This observational, prospective cohort study investigated…”
Get full text

Abstract P1-12-01: Dose-dense sequential adjuvant chemotherapy in the trastuzumab era: Final long-term results of the hellenic cooperative oncology group phase III HE10/05 trial by Zagouri, Flora, Koliou, Georgia-Angeliki, Dimitrakopoulos, Foteinos, Papadimitriou, Christos, Binas, Ioannis, Koutras, Angelos, Papakostas, Pavlos, Markopoulos, Christos, Venizelos, Vasileios, Xepapadakis, Grigorios, Karanikiotis, Charisios, Psyrri, Amanda, Bafaloukos, Dimitrios, Kosmidis, Paris, Aravantinos, Gerasimos, Res, Eleni, Mauri, Davide, Koumarianou, Anna, Petraki, Kalliopi, Tsipoura, Anna, Pectasides, Dimitrios, Gogas, Helen, Fountzilas, George

“…Abstract Background: Dose-dense sequential chemotherapy based on anthracyclines and taxanes has achieved an 18% reduction of recurrence risk in the adjuvant…”
Get full text

Evaluation of the Role of p95 HER2 Isoform in Trastuzumab Efficacy in Metastatic Breast Cancer by Rigakos, Georgios, Razis, Evangelia, Koliou, Georgia-Angeliki, Oikonomopoulos, Georgios, Tsolaki, Eleftheria, Sperinde, Jeff, Chrisafi, Sofia, Zarkavelis, George, Pazarli, Elissavet, Batistatou, Anna, Kourea, Helen P, Papakostas, Pavlos, Bafaloukos, Dimitrios, Asimakopoulou, Natalia I, Res, Eleni, Kotsakis, Athanasios, Pectasides, Dimitrios, Koutras, Angelos, Christodoulou, Christos, Fountzilas, George

“…Human epidermal growth factor receptor 2 (HER2) P95-isoform could be involved in trastuzumab resistance in HER2 metastatic breast cancer. A total of 114…”
Get full text

Metastatic malignancies and the effect on arterial stiffness and blood pressure levels: the possible role of chemotherapy by Res, Eleni, Kyvelou, Stella Maria, Vlachopoulos, Charalambos, Manousou, Kyriaki, Tousoulis, Dimitris, Stefanadis, Christodoulos, Pektasides, Dimitris

“…The aim of the prospective study was to evaluate blood pressure (BP) and the arterial stiffness before and after chemotherapy in three subgroups of patients…”
Get full text

Phase II study of cabazitaxel as second-line treatment in patients with HER-2 negative metastatic breast cancer previously treated with taxanes by Koutras, Angelos, Zagouri, Flora, Koliou, Georgia-Angeliki, Lazaridis, Georgios, Tryfonopoulos, Dimitrios, Kotsakis, Athanasios, Res, Eleni, Kentepozidis, Nikolaos K., Razis, Evangelia, Psyrri, Amanda, Koumakis, Georgios, Kalofonos, Haralabos, Fountzilas, George, Dimopoulos, Meletios A.

“…Abstract only…”
Get full text

Association between CD8+ Tumor Infiltrating Lymphocytes and the Clinical Outcome of Patients with Operable Breast Cancer Treated with Adjuvant Dose-Dense Chemotherapy-A 10 Year Follow-Up Report of a Hellenic Cooperative Oncology Group Observational Study by Spathas, Nikolaos, Goussia, Anna C, Koliou, Georgia-Angeliki, Gogas, Helen, Zagouri, Flora, Batistatou, Anna, Charchanti, Antonia V, Papoudou-Bai, Alexandra, Bobos, Mattheos, Chrisafi, Sofia, Chatzopoulos, Kyriakos, Kostopoulos, Ioannis, Koletsa, Triantafyllia, Arapantoni, Petroula, Pectasides, Dimitrios, Galani, Eleni, Koutras, Angelos, Zarkavelis, George, Saloustros, Emmanouil, Bafaloukos, Dimitrios, Karanikiotis, Charisios, Bompolaki, Iliada, Aravantinos, Gerasimos, Psyrri, Amanda, Razis, Evangelia, Koumarianou, Anna, Res, Eleni, Linardou, Helena, Fountzilas, George

“…Tumor-infiltrating lymphocytes (TILs) contribute to breast cancer (BC) prognosis. We investigated the prognostic impact of CD8+ TILs in patients with early…”
Get full text

Clinical Significance of Major Angiogenesis-Related Effectors in Patients with Metastatic Breast Cancer Treated with Trastuzumab-based Regimens by Kourea, Helen P, Dimitrakopoulos, Foteinos-Ioannis, Koliou, Georgia-Angeliki, Batistatou, Anna, Papadopoulou, Kyriaki, Bobos, Mattheos, Asimaki-Vlachopoulou, Anthoula, Chrisafi, Sofia, Pavlakis, Kitty, Chatzopoulos, Kyriakos, Galani, Eleni, Pentheroudakis, George, Pectasides, Dimitrios, Bafaloukos, Dimitrios, Res, Eleni, Papakostas, Pavlos, Koutras, Angelos, Kotoula, Vassiliki, Fountzilas, George

“…Angiogenesis is a crucial phenomenon in the development and progression of breast cancer (BC), but the clinical significance of angiogenesis-related proteins…”
Get full text

Real-world clinical outcome and toxicity data and economic aspects in patients with advanced breast cancer treated with cyclin-dependent kinase 4/6 (CDK4/6) inhibitors combined with endocrine therapy: the experience of the Hellenic Cooperative Oncology Group by Fountzilas, Elena, Koliou, Georgia-Angeliki, Vozikis, Athanassios, Rapti, Vassiliki, Nikolakopoulos, Achilleas, Boutis, Anastasios, Christopoulou, Athina, Kontogiorgos, Ioannis, Karageorgopoulou, Sofia, Lalla, Efthalia, Tryfonopoulos, Dimitrios, Boukovinas, Ioannis, Rapti, Cleopatra, Nikolaidi, Adamantia, Karteri, Sofia, Moirogiorgou, Evangelia, Binas, Ioannis, Mauri, Davide, Aravantinos, Gerasimos, Zagouri, Flora, Saridaki, Zacharenia, Psyrri, Amanda, Bafaloukos, Dimitrios, Koumarianou, Anna, Res, Eleni, Linardou, Helena, Mountzios, Giannis, Razis, Evangelia, Fountzilas, George, Koumakis, Georgios

“…BackgroundWe evaluated real-world clinical outcomes and toxicity data and assessed treatment-related costs in patients with advanced breast cancer who received…”
Get full text

mRNA expression of specific HER ligands and their association with clinical outcome in patients with metastatic breast cancer treated with trastuzumab by Rapti, Vassiliki, Moirogiorgou, Evangelia, Koliou, Georgia-Angeliki, Papadopoulou, Kyriaki, Binas, Ioannis, Pentheroudakis, George, Bafaloukos, Dimitrios, Bobos, Mattheos, Chatzopoulos, Kyriakos, Chrisafi, Sofia, Christodoulou, Christos, Nicolaou, Irene, Sotiropoulou, Maria, Magkou, Christina, Koutras, Angelos, Papakostas, Pavlos, Kotsakis, Athanasios, Razis, Evangelia, Psyrri, Amanda, Tryfonopoulos, Dimitrios, Pectasides, Dimitrios, Res, Eleni, Alexopoulos, Athanasios, Kotoula, Vassiliki, Fountzilas, George

“…Prognostic and predictive biomarkers are being studied for the diagnosis and treatment of breast cancer. The present study retrospectively assessed the mRNA…”
Get full text

Relapsed and De Novo Metastatic HER2-positive Breast Cancer Treated With Trastuzumab: Tumor Genotypes and Clinical Measures Associated With Patient Outcome by Kotoula, Vassiliki, Tsakiri, Kalliopi, Koliou, Georgia-Angeliki, Lazaridis, Georgios, Papadopoulou, Kyriaki, Giannoulatou, Eleni, Tikas, Ioannis, Christodoulou, Christos, Chatzopoulos, Kyriakos, Bobos, Mattheos, Pentheroudakis, George, Tsolaki, Eleftheria, Batistatou, Anna, Kotsakis, Athanassios, Koutras, Angelos, Linardou, Helena, Razis, Evangelia, Res, Eleni, Pectasides, Dimitrios, Fountzilas, George

“…We examined tumor genotype characteristics of human epidermal growth factor receptor 2 (HER2)-positive relapsed (R-) and de novo (dn-) metastatic breast cancer…”
Get full text

Genotyping KRAS and EGFR Mutations in Greek Patients With Non-small-cell Lung Cancer: Incidence, Significance and Implications for Treatment by Linardou, Helena, Kotoula, Vassiliki, Kouvatseas, George, Mountzios, Giannis, Karavasilis, Vasilios, Samantas, Epaminondas, Kalogera-Fountzila, Anna, Televantou, Despina, Papadopoulou, Kyriaki, Mavropoulou, Xanthipi, Daskalaki, Emily, Zaramboukas, Thomas, Efstratiou, Ioannis, Lampaki, Sofia, Rallis, Grigorios, Res, Eleni, Syrigos, Konstantinos N, Kosmidis, Paris A, Pectasides, Dimitrios, Fountzilas, George

“…KRAS mutations are reported in 20-25% of non-small cell lung cancer (NSCLC) and their prognostic role is unclear. We studied KRAS and EGFR genotyping in Greek…”
Get full text

An Observational Study to Assess the Molecular Epidemiology and Direct Medical Costs of Epidermal Growth Factor Receptor by Res, Eleni, Lampaki, Sofia, Kontogiorgos, Loannis, Linardou, Helena, Christopoulou, Athina, Lalla, Efthalia, Spyratos, Dionisios, Bafaloukos, Dimitrios, Fountzilas, George, Koliou, Georgia-Angeliki, Grivas, Anastasios, Rigakos, Georgios, Papantoniou, Panagiotis, Pastelli, Nicoleta, Koufaki, Margarita-loanna, Aravantinos, Gerasimos, Mountzios, Giannis, Boutis, Anastasios, Vozikis, Athanassios, Koumarianou, Anna, Papakotoulas, Pavlos, Oikonomopoulos, Georgios

“…Purpose: Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are the preferred first-line option for patients with advanced, EGFR-mutant…”
Get full text

An Observational Study to Assess the Molecular Epidemiology and Direct Medical Costs of Epidermal Growth Factor Receptor (EGFR) Mutations in Patients with Advanced EGFR Mutation-Positive Non-Small Cell Lung Cancer Treated with Afatinib in Real-World Clinical Settings in Greece by Mountzios, Giannis, Lampaki, Sofia, Koliou, Georgia-Angeliki, Vozikis, Athanassios, Kontogiorgos, Ioannis, Papantoniou, Panagiotis, Koufaki, Margarita-Ioanna, Res, Eleni, Boutis, Anastasios, Christopoulou, Athina, Pastelli, Nicoleta, Grivas, Anastasios, Aravantinos, Gerasimos, Lalla, Efthalia, Oikonomopoulos, Georgios, Koumarianou, Anna, Spyratos, Dionisios, Bafaloukos, Dimitrios, Rigakos, Georgios, Papakotoulas, Pavlos, Fountzilas, George, Linardou, Helena

“…Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are the preferred first-line option for patients with advanced, EGFR-mutant non-small…”
Get full text